Bahrain vs Tonga: Tuberculosis patients living with HIV receiving antiretroviral therapy
Bahrain
1 patients
in 2021
Tonga
1 patients
in 2021
Bahrain rank
130th
Tonga rank
130th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Bahrain
- Tonga
How they compare
Bahrain currently reports 1 patients against 1 patients in Tonga, a difference of 0 patients.
The two have swapped places 6 times across 14 shared years of data; in 2006 it was Tonga ahead.
Bahrain ranks 130th and Tonga ranks 130th of 183 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.25 patients | 0 patients | 0.25 patients | Bahrain |
| 2010s | 1.88 patients | 0 patients | 1.88 patients | Bahrain |
| 2020s | 2 patients | 0.5 patients | 1.5 patients | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Bahrain or Tonga?
- Bahrain, at 1 patients against 1 patients in Tonga as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Bahrain and Tonga?
- 0 patients, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Tonga?
- 14 years are reported by both, from 2006 to 2021.
- How do Bahrain and Tonga rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Bahrain ranks 130th and Tonga ranks 130th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.